|
AXSM Axsome Therapeutics Inc 1579428 |
| Balance Sheet |
|
Current Assets
|
485,064,000 |
|
Assets
|
568,498,000 |
|
Current Liabilities
|
230,104,000 |
|
Liabilities
|
511,483,000 |
|
Equity
|
57,015,000 |
|
Shares Out
|
48,000,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-128,410,000 |
|
Investing Cash Flow
|
-270,000 |
| Market Analysis |
Market Cap
|
4,377,378,224 |
|
Price
|
125.37 |
|
BVPS
|
1.19 |
|
PB
|
105.03 |
|
EPS
|
-6.51 |
|
PS
|
2.84 |
|
FCF
|
-128,680,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AXSM documents filed with the SEC.
AXSM Filings
Clear
